TKMS: Analyst Split Widens as Canadian Submarine Deal Pits Optimists Against Skeptics
Published on 07/12/2026 at 08:06 | Redaktion boerse-global.de
The pitch on TKMS has rarely been more compelling on paper — a preferred-bidder designation for a dozen submarines for Canada, an order book on the cusp of doubling, and year-to-date gains of nearly 18%. Yet the stock closed Friday at €81.70, down 4.22% on the day, and the real story lies in how starkly analysts disagree over what comes next.
That divergence is unusually wide. Price targets span from €76 at Bernstein Research to €135 at mwb research, with Deutsche Bank sitting in between at €110. The spread reflects a fundamental disagreement: can ThyssenKrupp Marine Systems actually convert its multibillion-euro order pipeline into sustainable earnings, or have investors already priced in too much?
The catalyst for the latest tug-of-war is the Canadian government’s decision to name TKMS as the preferred bidder for a new submarine fleet of up to 12 boats. Delivery is scheduled for 2034, and CEO Oliver Burkhard has expressed confidence that final contract negotiations will proceed smoothly. The German government is backing the effort, and if the deal goes through, TKMS’s backlog — currently around €20 billion — could vault past €40 billion, securing years of revenue visibility.
The optimists argue that this is a watershed moment. Deutsche Bank reiterated its buy recommendation after the Canadian news, pointing out that TKMS has now effectively swept every open multibillion-euro tender in which it competed. mwb research went a step further, lifting its target to €135 and maintaining a buy rating. Technically, the stock still sits 3.81% above its 50-day moving average of €78.70, and the relative strength index at 51.0 is comfortably neutral — leaving room for further upside if fresh positive catalysts emerge.
Should investors sell immediately? Or is it worth buying TKMS?
But the bears see a different picture. Bernstein Research sticks to a market-perform rating with a €76 target, arguing that the current valuation already embeds most of the good news. Analyst Adrien Rabier notes that European defense stocks are becoming increasingly decoupled from one another, and for the second quarter he prefers names like Leonardo, Thales and Rheinmetall — companies with nearer-term improvement potential from their own operational efforts. The implication is clear: TKMS’s share price may have run ahead of its execution reality.
The numbers lend weight to the caution. The 100-day moving average sits at €83.22, meaning Friday’s close remains below that threshold. The stock is still 20.60% off its 52-week high of €102.90, reached in late January, and on a weekly basis it shed 2.39%. The annualized 30-day volatility stands at a staggering 82.25% — a level that tends to amplify sudden moves in either direction and makes the stock far harder to value than a typical blue chip.
Execution risk is a genuine concern. While TKMS has been named the preferred supplier, the final contract terms and the involvement of Canadian suppliers such as CAE still need to be hammered out over the coming months. That creates a fog around near-term earnings visibility. The wide analyst target range itself is a warning: when professionals disagree that sharply, uncertainty is high.
TKMS at a turning point? This analysis reveals what investors need to know now.
For now, TKMS commands a market capitalization of €5.45 billion, a size that makes the potential Canadian award a material growth driver. Over the past 30 days the stock has gained 13.47%, and since the start of 2026 it is up 17.98%. But the recent weekly decline and the failure to reclaim the 100-day moving average suggest the market is waiting for proof.
The next hard test will come with quarterly results, which must show whether the wave of announced megadeals is beginning to translate into cash flow and margins. At the same time, progress on Canadian contract negotiations will be the most immediate catalyst. With volatility above 80%, sentiment can shift swiftly. For TKMS, the battle between the optimists and the skeptics is far from settled — and the next move could be decisive.
Ad
TKMS Stock: New Analysis - 12 July
Fresh TKMS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
